GMED
$71.70
Globus Medical
$1.28
1.82%
GMED
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  $0.44
Revenue:  $211.55 Mil
Tuesday
Aug 3
4:15 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Tuesday, May 4, 2021

What do you expect when GMED reports earnings?
Beat
Meet
Miss

Where is GMED's stock price going from here?
Up
Flat
Down
Stock chart of GMED
Analysts
Summary of analysts' recommendations for GMED
Score
Grade
Pivots
Resistance
$72.30
$71.83
$71.12

$70.65

Support
$69.94
$69.47
$68.76
Tweet
Growth
Description
Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania.
Peers
StrykerBoston ScientificBaxter InternationalBecton, DickinsonAbbottWaters3MCardiovascular SystemsResMedTeleflex